Yamin Sallowm, MD
Interventional Pain Medicine · Rancho Mirage, CANPI 1699138008
Payments from drug & device makers
What this record shows
This record is dominated by grants: $15,000 of the $16,148 with a category attached, or 92.9%. Medtronic accounts for 93.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $15,000 and has fallen 99.4% since, to $94 in 2025.
Across 21 payments — averaging $768.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Nevro Corp.$341
- Boston Scientific$256
- Avanos Medical$146
- Novartis$125
- Abbott$61
- plus $97 from 4 others
What the payments were for
- Grants$15,00093%
- Travel & lodging$410%
- Food & beverage$1,1077%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $15,123 |
| Nevro Corp. | 4 | $341 |
| Boston Scientific | 3 | $256 |
| Avanos Medical | 3 | $146 |
| Novartis | 1 | $125 |
| Abbott | 3 | $61 |
| Nalu Medical, Inc. | 1 | $29 |
| Globus Medical | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$15,000
- Senza$174
- Omnia$146
- ADAKVEO$125
- SPECTRA WAVEWRITER$124
How this compares
$16,148 in reported general payments places this provider in the 80th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 13 | $1,874 |
| Oxycodone Hcl | 48 | $1,669 |
| Gabapentin | 155 | $1,627 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $1,314 |
| Pregabalin | 107 | $1,196 |
| Duloxetine Hcl | 83 | $1,150 |
| Methocarbamol | 83 | $849 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $819 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $597 |
| Tizanidine Hcl | 47 | $512 |
| Diclofenac Sodium | 14 | $277 |
| Cyclobenzaprine Hcl | 26 | $245 |
| Baclofen | 30 | $203 |
| Meloxicam | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Rancho Mirage
- Tim LeierRancho Mirage$449K
- Andrew GermanovichRancho Mirage$333K
- Michael Verdolinla Mesa$507K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
- Patrick BuchananCamarillo$219K
- Chau VuSanta Rosa$141K
- Phillip LimBuena Park$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.